2-Hydroxy-N-phenylacetamide, 95.0%, 5g

N-(4-acetylphenyl)acetamide, 98.0%, 1g

(3aR,4R,5R,6aS)-2-Oxo-4-((R,E)-3-oxo-4-(m-tolyl)pent-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-5-yl benzoate, 98%, 50mg

7-Bromothiochroman-4-one, 95+%, 5g

2,3-dimethyl-4'-piperidinomethyl benzophenone, 97.0%, 1g

N-(3-Bromopropyl)phthalimide>98.0%(HPLC)(N)500g

6-oxo-1,6-dihydropyrimidine-5-carboxamide, 95%, 100mg

6-(Phenylamino)quinoline-5,8-dione, 100mg

(S)-(4-(2-((tert-Butoxycarbonyl)amino)-3-methoxy-3-oxopropyl)phenyl)boronic acid, 95.0%, 100mg

(2,2-Dichlorocyclopropyl)benzene>98.0%(GC)5g

1,2-Phenylene dimaleimide, 99.0%, 1g

Soluzione di acido borico 4%, pa, 5 l, confezione di plastica.

N,N'-Dimethyl-N,N'-bis(2-pyridylmethyl)ethane-1,2-diamine, 97%, 100mg